Furthermore, the knockdown of COPZ2 significantly inhibited the proliferation, migration, and invasion abilities of U251 and U87 cells via inhibition of the PI3K/AKT signaling pathway, indicating that COPZ2 could promote the progression of glioma. Here, COPZ2 is linked to central nervous system cancer.